{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T22:40:50Z","timestamp":1795128050043,"version":"4.10.3"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title>\n          <jats:p>Morcellation is a surgical technique used to reduce the size of the uterus or myomas by creating smaller pieces to allow the tissue to be removed through small incisions or with laparoscopic instruments. Open (uncontained) morcellation of the uterus and myomas has been scrutinized because of the possible spread of an unsuspected leiomyosarcoma while using a power morcellator during a hysterectomy or myomectomy for presumed symptomatic uterine leiomyomas. Before considering morcellation of the uterus, a woman should be evaluated to determine if she is at increased risk of malignancy of the uterine corpus. Morcellation of a malignancy is contraindicated and women should be evaluated preoperatively to identify malignancy. However, leiomyosarcoma cannot be reliably diagnosed preoperatively; thus, there is a risk that a woman with a presumed leiomyoma may have a malignancy that may be spread through morcellation, leading to a potentially worsened prognosis. Although an abdominal hysterectomy or myomectomy may reduce the chance of spreading cancer cells in women with undiagnosed leiomyosarcoma, it is associated with increased morbidity when compared with minimally invasive approaches. The obstetrician\u2013gynecologist and patient should engage in shared decision making, including informed consent, explaining the risks and benefits of each approach to surgery for presumed leiomyomas, the risks and benefits of morcellation, and alternatives to morcellation.<\/jats:p>","DOI":"10.1097\/aog.0000000000004291","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T21:00:48Z","timestamp":1614373248000},"page":"e63-e74","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":66,"title":["Uterine Morcellation for Presumed Leiomyomas"],"prefix":"10.1097","volume":"137","member":"276","reference":[{"key":"R2-20250423","first-page":"374","article-title":"Vaginal hysterectomy by morcellation","volume":"45","author":"Pratt","year":"1970","journal-title":"Mayo Clin Proc"},{"key":"R3-20250423","first-page":"471","article-title":"Electrical cutting device for laparoscopic removal of tissue from the abdominal cavity","volume":"81","author":"Steiner","year":"1993","journal-title":"Obstet Gynecol"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"98.e1","DOI":"10.1016\/j.ajog.2015.08.047","article-title":"Practice patterns and postoperative complications before and after U.S. Food and Drug Administration safety communication on power morcellation","volume":"214","author":"Harris","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20250423","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/AOG.0000000000002058","article-title":"Trends in mode of hysterectomy after the U.S. Food and Drug Administration power morcellation advisory","volume":"129","author":"Ottarsdottir","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/AOG.0000000000002035","article-title":"Changes in myomectomy practice after the U.S. Food and Drug Administration safety communication on power morcellation","volume":"129","author":"Stentz","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"e180141","DOI":"10.1001\/jamasurg.2018.0141","article-title":"Practice patterns and complications of benign hysterectomy following the FDA statement warning against the use of power morcellation","volume":"153","author":"Multinu","year":"2018","journal-title":"JAMA Surg"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmig.2014.08.781","article-title":"Outcome of occult uterine leiomyosarcoma after surgery for presumed uterine fibroids: a systematic review","volume":"22","author":"Pritts","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2013.11.024","article-title":"The value of re-exploration in patients with inadvertently morcellated uterine sarcoma","volume":"132","author":"Oduyebo","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R11-20250423","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1002\/cncr.28844","article-title":"Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma","volume":"120","author":"George","year":"2014","journal-title":"Cancer"},{"key":"R14-20250423","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/ijc.22239","article-title":"Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases","volume":"119","author":"Toro","year":"2006","journal-title":"Int J Cancer"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2017.02.012","article-title":"Prognosis and treatment of uterine leiomyosarcoma: a National Cancer Database study","volume":"145","author":"Seagle","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1525-1438.2007.01025.x","article-title":"The risk of developing uterine sarcoma after tamoxifen use","volume":"18","author":"Lavie","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2017.02.019","article-title":"Uterine leiomyosarcoma: epidemiology, contemporary treatment strategies and the impact of uterine morcellation","volume":"145","author":"Ricci","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R18-20250423","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/jnci\/91.19.1654","article-title":"Tamoxifen therapy for breast cancer and endometrial cancer risk","volume":"91","author":"Bernstein","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R19-20250423","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/AOG.0000000000002334","article-title":"Tissue extraction techniques for leiomyomas and uteri during minimally invasive surgery","volume":"130","author":"Siedhoff","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1634\/theoncologist.2016-0079","article-title":"Sarcomas associated with genetic cancer predisposition syndromes: a review","volume":"21","author":"Farid","year":"2016","journal-title":"Oncologist"},{"key":"R21-20250423","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ygyno.2011.10.019","article-title":"Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma","volume":"124","author":"Francis","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R22-20250423","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1097\/IGC.0000000000000261","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas","volume":"24","author":"Hensley","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R23-20250423","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4065\/82.11.1409","article-title":"Sarcoma","volume":"82","author":"Skubitz","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"R24-20250423","first-page":"e111","article-title":"Cervical cancer screening and prevention. Practice Bulletin No. 168. American College of Obstetricians and Gynecologists","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R25-20250423","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. ACS-ASCCP-ASCP Cervical Cancer Guideline Committee","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R26-20250423","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force Recommendation Statement. U.S. Preventive Services Task Force","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"R27-20250423","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/AOG.0b013e318262e320","article-title":"Diagnosis of abnormal uterine bleeding in reproductive-aged women. Practice Bulletin No. 128. American College of Obstetricians and Gynecologists","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R28-20250423","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/AOG.0000000000001242","article-title":"Risk of occult uterine sarcoma in women undergoing hysterectomy for benign indications [published erratum appears in Obstet Gynecol 2016;127:968]","volume":"127","author":"Kho","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R29-20250423","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/ijgc-00009577-200207000-00005","article-title":"Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus","volume":"12","author":"Goto","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"R30-20250423","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1002\/jmri.26630","article-title":"MRI screening for uterine leiomyosarcoma","volume":"49","author":"Tong","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"R33-20250423","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10397-015-0894-4","article-title":"The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis","volume":"12","author":"Pritts","year":"2015","journal-title":"Gynecol Surg"},{"key":"R34-20250423","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00404-015-3696-z","article-title":"Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH)","volume":"292","author":"Bojahr","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"R36-20250423","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ygyno.2011.04.021","article-title":"The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma","volume":"122","author":"Park","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R37-20250423","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2014.11.011","article-title":"Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis","volume":"137","author":"Bogani","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R38-20250423","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/AOG.0000000000001187","article-title":"Occult uterine sarcoma and leiomyosarcoma: incidence of and survival associated with morcellation [published erratum appears in Obstet Gynecol 2016;127:405]","volume":"127","author":"Raine-Bennett","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R39-20250423","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1525-1438.2007.01126.x","article-title":"Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease","volume":"18","author":"Einstein","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R40-20250423","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1097\/AOG.0000000000002112","article-title":"Choosing the route of hysterectomy for benign disease. ACOG Committee Opinion No. 701. American College of Obstetricians and Gynecologists","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R41-20250423","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/AOG.0000000000002034","article-title":"Minimally invasive hysterectomy and power morcellation trends in a west coast integrated health system","volume":"129","author":"Zaritsky","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R42-20250423","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jmig.2012.12.001","article-title":"Hand-assisted approach to laparoscopic myomectomy and hysterectomy","volume":"20","author":"Tusheva","year":"2013","journal-title":"J Minim Invasive Gynecol"},{"key":"R43-20250423","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/GCO.0000000000000435","article-title":"Morcellation equipment: past, present, and future","volume":"30","author":"Miller","year":"2018","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R44-20250423","doi-asserted-by":"crossref","first-page":"257.e1","DOI":"10.1016\/j.ajog.2015.08.076","article-title":"Contained tissue extraction using power morcellation: prospective evaluation of leakage parameters","volume":"214","author":"Cohen","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R45-20250423","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ijgo.13062","article-title":"Safety and efficacy of contained manual morcellation during laparoscopic or robotic gynecological surgery","volume":"148","author":"Hong","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"R46-20250423","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jmig.2019.01.014","article-title":"Cell spillage after contained electromechanical morcellation using a specially designed in-bag system for laparoscopic myomectomy: prospective cohort pilot study","volume":"26","author":"Lambat Emery","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"key":"R47-20250423","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/GCO.0000000000000280","article-title":"Updates in uterine fibroid tissue extraction","volume":"28","author":"Cohen","year":"2016","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R48-20250423","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/AOG.0000000000001039","article-title":"Uncontained compared with contained power morcellation in total laparoscopic hysterectomy","volume":"126","author":"Winner","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R49-20250423","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jogc.2019.11.004","article-title":"Morcellation during total laparoscopic hysterectomies: implications of the use of a contained bag system","volume":"42","author":"Gil-Gimeno","year":"2020","journal-title":"J Obstet Gynaecol Can"},{"key":"R50-20250423","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jmig.2014.11.010","article-title":"Open power morcellation versus contained power morcellation within an insufflated isolation bag: comparison of perioperative outcomes","volume":"22","author":"Vargas","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"R51-20250423","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/AOG.0b013e3182841594","article-title":"Complications of hysterectomy","volume":"121","author":"Clarke-Pearson","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R52-20250423","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10397-013-0781-9","article-title":"Abdominal versus laparoscopic hysterectomies for benign diseases: evaluation of morbidity and mortality among 465,798 cases","volume":"10","author":"Wiser","year":"2013","journal-title":"Gynecol Surg"},{"key":"R55-20250423","doi-asserted-by":"crossref","first-page":"djv251","DOI":"10.1093\/jnci\/djv251","article-title":"Economic and survival implications of use of electric power morcellation for hysterectomy for presumed benign gynecologic disease","volume":"107","author":"Wright","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"R56-20250423","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejogrb.2015.09.044","article-title":"Fibroid morcellation: a shared clinical decision tool for mode of hysterectomy","volume":"195","author":"Hur","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R57-20250423","doi-asserted-by":"crossref","first-page":"591.e1","DOI":"10.1016\/j.ajog.2015.03.006","article-title":"Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a decision analysis","volume":"212","author":"Siedhoff","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R58-20250423","doi-asserted-by":"crossref","first-page":"259.e1","DOI":"10.1016\/j.ajog.2016.11.1039","article-title":"Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications","volume":"216","author":"Siedhoff","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R59-20250423","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/IGC.0000000000000558","article-title":"Morcellation and the incidence of occult uterine malignancy: a dual-institution review","volume":"26","author":"Picerno","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"R60-20250423","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jmig.2013.08.002","article-title":"Risk of incidental finding of endometrial cancer at the time of hysterectomy for benign condition","volume":"21","author":"Ouldamer","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"R61-20250423","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ijgo.12111","article-title":"Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease","volume":"137","author":"Von Bargen","year":"2017","journal-title":"Int J Gynaecol Obstet"},{"key":"R62-20250423","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jmig.2016.01.017","article-title":"Nonmalignant sequelae of unconfined morcellation at laparoscopic hysterectomy or myomectomy","volume":"23","author":"Tulandi","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"key":"R63-20250423","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/AOG.0b013e3181b48f7f","article-title":"Informed consent. ACOG Committee Opinion No. 439. American College of Obstetricians and Gynecologists","volume":"114","year":"2009","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T19:02:38Z","timestamp":1745434958000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004291"}},"subtitle":["ACOG Committee Opinion, Number 822"],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004291","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}